2022 Q1 Form 10-Q Financial Statement

#000095017022009644 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2020 Q2
Revenue $9.357M $7.101M $6.120M
YoY Change 31.77% 67.32% -17.56%
Cost Of Revenue $4.156M $2.000M $1.520M
YoY Change 107.8% 238.98% -54.63%
Gross Profit $5.201M $5.110M $4.600M
YoY Change 1.78% 39.62% 12.75%
Gross Profit Margin 55.58% 71.96% 75.16%
Selling, General & Admin $4.275M $3.969M $3.670M
YoY Change 7.71% 14.31% -0.76%
% of Gross Profit 82.2% 77.67% 79.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $133.0K $90.00K $90.00K
YoY Change 47.78% 0.0% 28.57%
% of Gross Profit 2.56% 1.76% 1.96%
Operating Expenses $4.275M $3.969M $3.750M
YoY Change 7.71% 14.31% 1.41%
Operating Profit $875.0K $1.046M $1.024M
YoY Change -16.35% 456.38% -34.78%
Interest Expense $44.00K $0.00 $170.0K
YoY Change -100.0% -86.4%
% of Operating Profit 5.03% 0.0% 16.6%
Other Income/Expense, Net
YoY Change
Pretax Income $837.0K $1.049M $1.020M
YoY Change -20.21% 1398.57% -34.11%
Income Tax $192.0K $17.00K -$1.020M
% Of Pretax Income 22.94% 1.62% -100.0%
Net Earnings $645.0K $1.032M $1.032M
YoY Change -37.5% 2615.79% -30.92%
Net Earnings / Revenue 6.89% 14.53% 16.86%
Basic Earnings Per Share $0.02 $0.03
Diluted Earnings Per Share $0.02 $0.03 $65.89K
COMMON SHARES
Basic Shares Outstanding 36.00M 34.79M 28.75M
Diluted Shares Outstanding 36.75M 37.53M 30.96M

Balance Sheet

Concept 2022 Q1 2021 Q1 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.10M $15.85M $2.230M
YoY Change -4.75% 412.94% -40.53%
Cash & Equivalents $15.10M $15.85M $2.233M
Short-Term Investments
Other Short-Term Assets $1.224M $450.0K $1.790M
YoY Change 172.0% -57.55% 175.38%
Inventory $2.857M $90.00K $609.0K
Prepaid Expenses
Receivables $2.882M $2.300M $1.900M
Other Receivables $2.088M $2.030M $800.0K
Total Short-Term Assets $24.15M $20.72M $7.324M
YoY Change 16.54% 201.16% -5.06%
LONG-TERM ASSETS
Property, Plant & Equipment $1.456M $960.0K $180.0K
YoY Change 51.67% -38.46% -0.55%
Goodwill $7.446M $5.585M
YoY Change -9.3%
Intangibles $4.460M
YoY Change
Long-Term Investments $6.544M $2.400M $3.360M
YoY Change 172.67% -13.36% -20.25%
Other Assets $49.00K $4.700M $241.0K
YoY Change -98.96% 683.33% 7.59%
Total Long-Term Assets $27.96M $18.27M $16.10M
YoY Change 53.04% 23.53% 5.44%
TOTAL ASSETS
Total Short-Term Assets $24.15M $20.72M $7.324M
Total Long-Term Assets $27.96M $18.27M $16.10M
Total Assets $52.11M $38.99M $23.43M
YoY Change 33.64% 79.93% 1.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.123M $7.200M $7.740M
YoY Change -56.63% -9.77% -28.66%
Accrued Expenses $505.0K $300.0K $540.0K
YoY Change 68.33% -48.28% 5.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.979M $240.0K
YoY Change -38.46%
Total Short-Term Liabilities $15.38M $7.500M $8.520M
YoY Change 105.08% -15.76% -27.65%
LONG-TERM LIABILITIES
Long-Term Debt $1.233M $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $2.127M $560.0K $55.00K
YoY Change 279.82% -30.86% -89.62%
Total Long-Term Liabilities $3.360M $560.0K $55.00K
YoY Change 500.0% -30.86% -92.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.38M $7.500M $8.520M
Total Long-Term Liabilities $3.360M $560.0K $55.00K
Total Liabilities $18.74M $8.070M $9.310M
YoY Change 132.23% -16.89% -29.1%
SHAREHOLDERS EQUITY
Retained Earnings -$260.1M
YoY Change
Common Stock $367.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $33.37M $30.92M $14.11M
YoY Change
Total Liabilities & Shareholders Equity $52.11M $38.99M $23.43M
YoY Change 33.64% 79.93% 1.94%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2020 Q2
OPERATING ACTIVITIES
Net Income $645.0K $1.032M $1.032M
YoY Change -37.5% 2615.79% -30.92%
Depreciation, Depletion And Amortization $133.0K $90.00K $90.00K
YoY Change 47.78% 0.0% 28.57%
Cash From Operating Activities $3.093M -$5.827M -$710.0K
YoY Change -153.08% 4838.14% -123.43%
INVESTING ACTIVITIES
Capital Expenditures $12.00K $23.00K $0.00
YoY Change -47.83% 360.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$966.0K -$1.570M -$80.00K
YoY Change -38.47% -366.1% -55.56%
Cash From Investing Activities -$978.0K -$1.588M -$80.00K
YoY Change -38.41% -373.32% -61.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -640.0K -118.0K -70.00K
YoY Change 442.37% 20.41% -92.22%
NET CHANGE
Cash From Operating Activities 3.093M -5.827M -710.0K
Cash From Investing Activities -978.0K -1.588M -80.00K
Cash From Financing Activities -640.0K -118.0K -70.00K
Net Change In Cash 1.475M -7.533M -860.0K
YoY Change -119.58% -2163.84% -144.79%
FREE CASH FLOW
Cash From Operating Activities $3.093M -$5.827M -$710.0K
Capital Expenditures $12.00K $23.00K $0.00
Free Cash Flow $3.081M -$5.850M -$710.0K
YoY Change -152.67% 4656.1% -123.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000849145
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39471
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
HERITAGE GLOBAL INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2291344
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
12625 High Bluff Drive
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 305
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
CY2022Q1 dei City Area Code
CityAreaCode
858
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
847-0659
CY2022Q1 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
HGBL
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36677837
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15097000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13622000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
122000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
122000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2882000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2732000
CY2022Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2088000
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2254000
CY2022Q1 us-gaap Inventory Net
InventoryNet
2857000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3220000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1224000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1456000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
24148000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
23284000
CY2022Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1078000
CY2021Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1784000
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
6544000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4683000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2569000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2694000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1456000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1471000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4460000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4565000
CY2022Q1 us-gaap Goodwill
Goodwill
7446000
CY2021Q4 us-gaap Goodwill
Goodwill
7446000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4358000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4488000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49000
CY2022Q1 us-gaap Assets
Assets
52108000
CY2021Q4 us-gaap Assets
Assets
50464000
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3123000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4793000
CY2022Q1 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
9774000
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
6451000
CY2022Q1 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
1979000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
505000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
501000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
15381000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14224000
CY2022Q1 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1233000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2127000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2249000
CY2022Q1 us-gaap Liabilities
Liabilities
18741000
CY2021Q4 us-gaap Liabilities
Liabilities
17825000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
565
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
565
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
565
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
565
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36677837
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36677837
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36574702
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36574702
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
367000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
366000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
293112000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
293030000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-260118000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-260763000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
33367000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32639000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52108000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50464000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9357000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7101000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4275000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3969000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
133000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
91000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
8564000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
6055000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
82000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
875000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1046000
CY2022Q1 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
38000
CY2021Q1 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
-3000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
837000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1049000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
645000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1032000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36003709
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34788016
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36749198
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37533065
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32639000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-23000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
106000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
645000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
33367000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
29943000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-120000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1032000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
30922000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
645000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1032000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
58000
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
49000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
82000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2022Q1 hgbl Noncash Lease Expense
NoncashLeaseExpense
125000
CY2021Q1 hgbl Noncash Lease Expense
NoncashLeaseExpense
133000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
133000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
91000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
130000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-48000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
106000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
143000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
150000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
801000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-232000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-363000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-144000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-55000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1672000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1802000
CY2022Q1 hgbl Increase Decrease Of Payables To Sellers
IncreaseDecreaseOfPayablesToSellers
3323000
CY2021Q1 hgbl Increase Decrease Of Payables To Sellers
IncreaseDecreaseOfPayablesToSellers
-4683000
CY2022Q1 hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-118000
CY2021Q1 hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-140000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3093000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5827000
CY2022Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0
CY2021Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2494000
CY2022Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
814000
CY2021Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
929000
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2118000
CY2021Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
338000
CY2021Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-978000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1588000
CY2022Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
617000
CY2021Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
CY2022Q1 hgbl Proceeds From Issuance Of Common Stock From Stock Option Awards
ProceedsFromIssuanceOfCommonStockFromStockOptionAwards
9000
CY2021Q1 hgbl Proceeds From Issuance Of Common Stock From Stock Option Awards
ProceedsFromIssuanceOfCommonStockFromStockOptionAwards
85000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
203000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-640000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-118000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1475000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7533000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13622000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23385000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15097000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15852000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
7000
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
32000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2136663
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Significant estimates include the assessment of collectability of revenue recognized and the valuation of accounts receivable and notes receivable, inventory, investments, goodwill and intangible assets, liabilities, deferred income tax assets and liabilities including projecting future years’ taxable income, and stock-based compensation. These estimates have the potential to significantly impact our consolidated financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.</span></p>
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Certain prior year balances within the consolidated financial statements have been reclassified to conform to current year presentation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q1 hgbl Percentage Of Revenue Specific To Customer From Net Revenue
PercentageOfRevenueSpecificToCustomerFromNetRevenue
0.07
CY2021Q1 hgbl Percentage Of Revenue Specific To Customer From Net Revenue
PercentageOfRevenueSpecificToCustomerFromNetRevenue
0.10
CY2022Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
3200000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
4000000.0
CY2022Q1 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
800000
CY2022Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
100000
CY2021Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
12500
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2193288
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.23
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
135000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.41
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
179125
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.49
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12500
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.13
CY2022Q1 hgbl Number Of Locations
NumberOfLocations
3
CY2020Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P90M
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2569000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2694000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M21D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
807000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
887038
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.67
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M10D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
661000
CY2021Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
25000
CY2019Q2 us-gaap Sale Leaseback Transaction Date
SaleLeasebackTransactionDate
The purchase option for both the real estate and machinery and equipment could be exercised at any time on or after December 1, 2019 and before May 31, 2021
CY2019Q2 us-gaap Sale Leaseback Transaction Net Book Value
SaleLeasebackTransactionNetBookValue
20000000.0
CY2022Q1 us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
the Company’s shares of Series N preferred shares, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock.
CY2022Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
40
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36003709
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34788016
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
745489
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2745049
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36749198
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37533065
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30000
CY2019Q1 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0525
CY2021Q2 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0495
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
461000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
568000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
532000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
398000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
377000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
700000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3036000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
404000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2632000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2128000
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2437000
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2437000
CY2021Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4565000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
105000
CY2022Q1 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4460000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
316000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
391000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
391000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
262000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
186000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
477000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2023000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1046000
CY2022Q1 us-gaap Goodwill
Goodwill
7446000
CY2021Q4 us-gaap Goodwill
Goodwill
7446000
CY2022Q1 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
1979000
CY2021Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
2479000
CY2022Q1 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1233000
CY2021Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1352000
CY2022Q1 us-gaap Loans Payable
LoansPayable
3212000
CY2021Q4 us-gaap Loans Payable
LoansPayable
3831000
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
77800000
CY2022Q1 hgbl Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
Substantially all of the net operating loss carry forwards expire between 2024 and 2037
CY2022Q1 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The Company’s utilization of restricted net operating tax loss carry forwards against future income for tax purposes is restricted pursuant to the “change in ownership” rules in Section 382 of the Internal Revenue Code.
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
875000

Files In Submission

Name View Source Status
0000950170-22-009644-index-headers.html Edgar Link pending
0000950170-22-009644-index.html Edgar Link pending
0000950170-22-009644.txt Edgar Link pending
0000950170-22-009644-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hgbl-20220331.htm Edgar Link pending
hgbl-20220331.xsd Edgar Link pending
hgbl-20220331_cal.xml Edgar Link unprocessable
hgbl-20220331_def.xml Edgar Link unprocessable
hgbl-20220331_htm.xml Edgar Link completed
hgbl-20220331_lab.xml Edgar Link unprocessable
hgbl-20220331_pre.xml Edgar Link unprocessable
hgbl-ex31_1.htm Edgar Link pending
hgbl-ex31_2.htm Edgar Link pending
hgbl-ex32_1.htm Edgar Link pending
hgbl-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending